Mark Sheptoff Financial Planning’s Anika Therapeutics ANIK Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-300	Closed	-$11K	–	427
2021 Q4	$11K	Hold	300	–	–	0.01%	308
2021 Q3	$13K	Hold	300	–	–	0.01%	281
2021 Q2	$13K	Hold	300	–	–	0.01%	304
2021 Q1	$12K	Hold	300	–	–	0.01%	277
2020 Q4	$14K	Hold	300	–	–	0.01%	247
2020 Q3	$11K	Hold	300	–	–	0.01%	226
2020 Q2	$11K	Hold	300	–	–	0.01%	249
2020 Q1	$9K	Hold	300	–	–	0.01%	240
2019 Q4	$16K	Hold	300	–	–	0.01%	234
2019 Q3	$16K	Hold	300	–	–	0.01%	228
2019 Q2	$12K	Hold	300	–	–	0.01%	253
2019 Q1	$9K	Hold	300	–	–	0.01%	270
2018 Q4	$10K	Hold	300	–	–	0.01%	241
2018 Q3	$13K	Hold	300	–	–	0.01%	270
2018 Q2	$10K	Hold	300	–	–	0.01%	274
2018 Q1	$15K	Hold	300	–	–	0.01%	251
2017 Q4	$16K	Hold	300	–	–	0.01%	249
2017 Q3	$17K	Hold	300	–	–	0.01%	248
2017 Q2	$15K	Sell	300 -1	-0.3%	-$46	0.01%	247
2017 Q1	$13K	Buy	301 +1	+0.3%	+$48	0.01%	259
2016 Q4	$15K	Hold	300	–	–	0.01%	242
2016 Q3	$14K	Hold	300	–	–	0.01%	243
2016 Q2	$16K	Hold	300	–	–	0.01%	224
2016 Q1	$13K	Hold	300	–	–	0.01%	232
2015 Q4	$11K	Hold	300	–	–	0.01%	263
2015 Q3	$10K	Hold	300	–	–	0.01%	249
2015 Q2	$10K	Sell	300 -200	-40%	-$7.13K	0.01%	271
2015 Q1	$21K	Hold	500	–	–	0.02%	211
2014 Q4	$20K	Sell	500 -600	-55%	-$23.5K	0.02%	215
2014 Q3	$40K	Sell	1,100 -200	-15%	-$8.64K	0.04%	179
2014 Q2	$60K	Buy	1,300 +1,000	+333%	+$44.5K	0.05%	165
2014 Q1	$12K	Buy	+300	New	+$11.2K	0.01%	268

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Mark Sheptoff Financial Planning's ANIK Position: Q1 2022 in Review

Mark Sheptoff Financial Planning sold out of Anika Therapeutics (ANIK) in Q1 2022, closing a stake of 300 shares — an estimated $11K sold.

Mark Sheptoff Financial Planning first reported a position in ANIK in Q1 2014 and held it in 32 quarters. The position peaked at $60K in Q2 2014. 118 funds tracked by Wall St. Rank hold ANIK as of Q1 2022.

Mark Sheptoff Financial Planning reported no remaining Anika Therapeutics position as of Q1 2022 after selling out during the quarter.
Mark Sheptoff Financial Planning sold 300 Anika Therapeutics shares in Q1 2022, an estimated $11K.
Mark Sheptoff Financial Planning first reported a position in Anika Therapeutics in Q1 2014 and held it in 32 quarters.
Mark Sheptoff Financial Planning's Anika Therapeutics position peaked at $60K in Q2 2014.
118 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2022.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2022, filed 12 May 2022.